Abstract
We carry out an analysis of gender differences in patterns of disease diagnosis across four large observational health datasets and find that women are routinely older when first assigned most diagnoses. Among 112 acute and chronic diseases, women experience longer lengths of time between symptom onset and disease diagnosis than men for most diseases regardless of metric used, even when only symptoms common to both genders are considered. These findings are consistent for patients with private as well as government insurance. Our analysis highlights systematic gender differences in patterns of disease diagnosis and suggests that symptoms of disease are measured or weighed differently for women and men. Data and code leverage the open-source common data model and analytic code and results are publicly available.
One-Sentence Summary In large populations, across insurance coverage and many conditions, women are older than men when diagnosed and experience longer time to diagnosis.
Competing Interest Statement
PBR and JH are employees of Janssen Research and shareholders of Johnson & Johnson. NE received research grant from Health of Women, Office of the Chief Medical Officer, Johnson & Johnson to support this research. All other authors declare no competing interests. Janssen and Johnson & Johnson had no input in the design, execution, interpretation of results, or decision to publish.
Funding Statement
This study was funded by the National Library of Medicine Training Award (T15LM007079) and Johnson and Johnson.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of Columbia University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Fixes to main-text content and edits to headers
Data and materials availability
Data used in this study are from standardized OMOP version of electronic health records and claims datasets. While the data are not publicly available, all raw summary results of the analysis are available upon request. Interactive visualizations of all study results are available on the companion website of the study at https://even.dbmi.columbia.edu/characterization. Code for analysis is available at https://github.com/elhadadlab/gender-differences-characterization.
